Chris Boshoff: New milestone with Flagship Pioneering
Chris Boshoff, Chief Oncology Officer and President of Research and Development at Pfizer, shared a post on LinkedIn:
“We achieved a new milestone with Flagship Pioneering, our sixth agreement under our strategic partnership that aims to accelerate the discovery of potential innovative compounds. Under a new agreement, Pioneering Medicines will engage Charles River to use the Logica platform, developed by Valo Health, to explore the discovery of novel, selective small molecule leads for the treatment of autoimmune disease. Read the full announcement.
Autoimmune diseases impose a substantial health burden on patients, and we look forward to leveraging a promising novel approach to potentially identify and advance disease-modifying candidate molecules that could have a positive impact for patients.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023